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Colloquium
Assembly of RecA-like recombinases: Distinct roles
for mediator proteins in mitosis and meiosis
Stephen L. Gasior*†, Heidi Olivares*, Uy Ear*, Danielle M. Hari*, Ralph Weichselbaum*, and Douglas K. Bishop*†‡
Departments of *Radiation and Cellular Oncology, and †Molecular Genetics and Cell Biology, University of Chicago, Chicago, IL 60637
Members of the RecA family of recombinases from bacteriophage
T4, Escherichia coli, yeast, and higher eukaryotes function in
recombination as higher-order oligomers assembled on tracts of
single-strand DNA (ssDNA). Biochemical studies have shown that
assembly of recombinase involves accessory factors. These studies
have identified a class of proteins, called recombination mediator
proteins, that act by promoting assembly of recombinase on ssDNA
tracts that are bound by ssDNA-binding protein (ssb). In the
absence of mediators, ssb inhibits recombination reactions by
competing with recombinase for DNA-binding sites. Here we
briefly review mediated recombinase assembly and present results
of new in vivo experiments. Immuno-double-staining experiments
in Saccharomyces cerevisiae suggest that Rad51, the eukaryotic
recombinase, can assemble at or near sites containing ssb (repli-
cation protein A, RPA) during the response to DNA damage,
consistent with a need for mediator activity. Correspondingly,
mediator gene mutants display defects in Rad51 assembly after
DNA damage and during meiosis, although the requirements for
assembly are distinct in the two cases. In meiosis, both Rad52 and
Rad55y57 are required, whereas either Rad52 or Rad55y57 is
sufficient to promote assembly of Rad51 in irradiated mitotic cells.
Rad52 promotes normal amounts of Rad51 assembly in the absence
of Rad55 at 30°C but not 20°C, accounting for the cold sensitivity
of rad55 null mutants. Finally, we show that assembly of Rad51 is
induced by radiation during S phase but not during G1, consistent
with the role of Rad51 in repairing the spontaneous damage that
occurs during DNA replication.
Homologous recombination reactions promote repair ofDNA ends formed by double-strand breaks (DSBs) and by
replication fork collapse. Recombinational repair also allows
cells to replicate past DNA lesions that block the progress of
DNA polymerase. In phage T4, recombination is critical for
initiating replication. In eukaryotes, homologous recombination
is critical for accurate reductional segregation of chromosomes
during meiosis. Finally, in prokaryotes, recombination allows
horizontal transfer of alleles among and between bacteria and
phage.
At the center of homologous recombination are the recom-
binases, proteins that promote the formation of heteroduplex
DNA. Of particular importance are the recombinases of the
RecA family, including RecA in eubacteria, RadA in archea,
Rad51 and Dmc1 in eukaryea, and the bacteriophage T4 UvsX
protein.
RecA-Like Recombinases Assemble on Single-Strand DNA (ssDNA).
Several of the RecA recombinases have been shown to act by
assembling into filaments on ssDNA (1–5). ssDNA tracts are
formed by nucleolytic processing of DNA ends and by stalling of
polymerase during DNA replication (6, 7). The nucleoprotein
filaments formed by assembly of recombinases on ssDNA are
capable of ‘‘searching’’ intact DNA duplexes for homologous
regions (8–11). Location of a homologous duplex by the recom-
binase filament results in formation of a homologous joint
between the ssDNA and the duplex and leads to strand exchange.
During strand exchange, the ssDNA contained within the nu-
cleoprotein filament forms Watson–Crick base pairs with the
complementary strand of the ‘‘target’’ duplex, displacing the
noncomplementary strand in the duplex. The hybrid DNA
formed by strand exchange is further processed by repair poly-
merase and other recombination factors, eventually yielding two
intact DNA duplexes (7, 8, 11, 12).
Accessory Factors Act to Promote Assembly of Recombinase. Recom-
binases are able to promote strand exchange to form hybrid
DNA in vitro without additional proteins. However, accessory
factors can stimulate strand exchange. These factors can be
divided into two broad classes: those that act before homology
search by promoting assembly of recombinase filaments, and
those that act during homology search and strand exchange.
Assembly factors can, in turn, be divided into two classes:
ssDNA-binding protein (ssb) and assembly ‘‘mediators.’’ Here
we focus on the roles of assembly factors. A general model for
the mechanism of recombinase assembly is shown in Fig. 1.
ssbs are involved in multiple pathways of DNA metabolism,
including replication, recombination, and repair. ssbs are abun-
dant; the abundance of bacteriophage T4 gp32 protein is 1–3 3
104 copiesyinfected cell (13), that of tetrameric Escherichia coli
SSB about 1–2 3 103ycell (14), and that of the heterotrimeric
RPA protein from eukaryotes about 104-105ycell (15). As their
name implies, ssbs bind ssDNA specifically. The relative binding
affinity (ssDNAydouble-strand DNA) is at least 106 for gp32
(16), at least 108 for SSB (D. T. Lohman, personal communi-
cation), and 70-fold for RPA (17). ssbs can bind ssDNA in a
cooperative manner, forming filaments that can readily saturate
long stretches of ssDNA (18).
ssbs can stimulate assembly of recombinases on ssDNA, but
their ability to do so depends highly on reaction conditions
(19–22). If an amount of ssb sufficient to saturate binding sites
on ssDNA is added to strand exchange reactions before addition
of recombinase, the reaction is inhibited. On the other hand, if
recombinase is added first to such reactions, strand exchange
activity is often stimulated compared with reactions containing
no ssb. Inhibition of recombinase by ssb results from its ability
to block initial binding of recombinase to ssDNA; ssb can
outcompete recombinases as a consequence of their higher
affinity and faster binding kinetics. A model that accounts for
these observations is as follows. ssb competes with recombinase
for initial binding sites on ssDNA. However, when recombinase
This paper results from the National Academy of Sciences colloquium, ‘‘Links Between
Recombination and Replication: Vital Roles of Recombination,’’ held November 10–12,
2000, in Irvine, CA.
Abbreviations: ssDNA, single-strand DNA; ssb, ssDNA-binding protein (generic); RPA, rep-
lication protein A; DSB, DNA double-strand break; CHO, Chinese hamster ovary; WT, wild
type.
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filaments are initiated, interactions that occur during recombi-
nase filament elongation displace ssb from DNA. Elongation of
recombinase filaments is blocked by DNA secondary structures,
whereas assembly of ssb filaments is not. As a result of these
properties, adding ssb to reactions after recombinase allows
recombinase the opportunity to initiate filaments on ssDNA
before ssb is added and then extend past sites of secondary
structure with the help of ssb. The recombinase filaments formed
as a result of ssb–recombinase interactions are more efficient in
strand exchange reactions than filaments formed by recombinase
alone because of persisting secondary structures in ssDNA.
RPA Assembles Before Rad51 After Radiation Treatment. Immuno-
staining techniques can detect assembly of recombination pro-
teins into subnuclear staining foci (23–32). Several lines of
evidence suggest that these foci represent protein oligomers
assembled at sites of DSBs and possibly daughter strand gaps as
well. Double staining shows that multiple proteins required for
recombination assemble at the same sites during recombination.
Such experiments in yeast and mammalian cells showed that
RPA colocalizes with Rad51 (29, 31–33). An important question
raised by the biochemical interaction of ssb and recombinase is:
Does ssb assemble before or after recombinase in vivo? The high
efficiency of binding to ssDNA and the abundance of ssb predict
that ssb will assemble more rapidly than recombinases on tracts
of ssDNA. However, the one previous experiment that addressed
the question of the relative timing of assembly of RPA and
Rad51 during recombination found that Rad51 foci assembled
first, with colocalizing RPA foci appearing at a later stage during
meiosis in mouse spermatocytes (33).
To determine the relative timing of appearance of RPA and
Rad51 foci after induction of damage by g-rays, a log phase
culture of diploid cells was arrested in G2yM with the microtu-
bule inhibitor nocodazole. Cells were arrested at the G2yM
phase of the cell cycle to avoid detection of the RPA foci that
form in undamaged cells as a normal part of S phase (29). In
addition to being arrested in G2yM, cells were treated with
zymolyase to remove the cell wall, which allowed rapid process-
ing of samples. After treatment of arrested cells with 50 krad, the
culture was incubated at 30°C for various times and spread nuclei
prepared for immunostaining. Fifty unselected surface-spread
nuclei were examined from each sample. The data are shown in
Fig. 2. Induction of RPA focus positive nuclei was detected
immediately after treatment, i.e., at the time point designated t 5
0 h. The RPA foci seen in these nuclei depend on irradiation,
because they did not appear in an untreated control. Induction
of Rad51 foci was not detected until t 5 0.25 h. The average
number of induced RPA-containing foci increased to a maxi-
mum of 33ynucleus at 2 h. Rad51 containing foci also peaked at
2 h (18ynucleus). At all times, the majority of Rad51-containing
foci (67–83%) also stained with RPA. The subset of Rad51 foci
that did not contain detectable amounts of RPA could result
from assembly of Rad51 at sites devoid of RPA. Alternatively,
they could result from displacement of RPA, epitope masking of
Fig. 1. Generic model for assembly of recombinase on ssb-coated ssDNA. (A)
Tracts of ssDNA form because of resection at DSB sites or stalling of polymer-
ase. (B) ssb assembles into oligomeric filaments on tracts of ssDNA, removing
secondary structures. (C) Mediator protein binds to ssb-coated DNA, causing
a local remodeling of the ssb filament. (D) Recombinase initiates filament
formation at sites of mediator-ssb-ssDNA. Recombinase filaments then elon-
gate displacing ssb. (E) The elongated recombinase filament searches for
homologous sequences. (F) Strand exchange occurs. The outgoing ssDNA
strand is bound by ssb.
Fig. 2. RPA assembles before Rad51 after g-irradiation of G2 arrested S.
cerevisiae spheroplasts. A diploid yeast strain (NKY1314, SK-1 strain back-
ground) was grown in rich medium and arrested in G2yM by treatment with
nocodazole. Cells were spheroplasted by zymolyase treatment, irradiated to
a dose of 50 krad with a 60Co source, and resuspended in osmotically stabilized
growth medium containing nocodazole. At the times indicated, culture ali-
quots were processed to obtain surface spread nuclei. Spread nuclei were
indirectly immunostained with polyclonal guinea pig anti-Rad51(green) and
rabbit anti-RPA70 (red), counter strained with a DNA-specific dye (DAPI), and
examined by epifluorescence microscopy. The number of foci per nucleus was
determined by visual examination of digital images. Details of the method
have been published (29, 59). (A) Representative nuclei from the times indi-
cated. Overlapping signals are yellow in these pseudocolored images. (B)
Average number of foci detected per nucleus at the times indicated.
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RPA by Rad51, or limited detection of RPA by the probe used.
The early appearance of RPA foci relative to Rad51 foci,
together with the observation that most Rad51-containing foci
also contained RPA, strongly suggests that Rad51 can assemble
at or near sites of previously assembled RPA.
Recombination Mediator Proteins. Given that ssb inhibits the ability
of recombinases to bind ssDNA in vitro when added to reactions
before ssb, a mechanism is needed to overcome the inhibitory
effect of ssb on recombinase assembly. So-called ‘‘mediator’’
proteins appear to play this role. These proteins promote
efficient formation of recombinase oligomers on ssDNA that are
coated with ssb (34, 35). The bacteriophage T4 UvsY was the
first protein to be shown to have mediator activity in vitro (21, 36,
37). In addition to overcoming inhibitory effects of gp32 on
UvsX, UvsY can stabilize UvsX filaments when formed (36, 37).
E. coli appears to have two distinct mechanisms for promoting
assembly of RecA. RecO and RecR act together as mediators to
overcome ssb-dependent inhibition of RecA-mediated strand
exchange (38, 39). A third protein, RecF, is likely to function
with RecO, and RecR in vivo and has been shown to be capable
of limiting the assembly of RecA to regions of ssDNA in vitro
(40). Genetic studies provide evidence that RecF, RecO, and
RecR function specifically during the repair of daughter strand
gaps caused by the stalling of polymerase (6).
The second RecA assembly mechanism involves the multi-
functional recombination protein RecBCD (41). RecBCD has
both exonuclease and helicase activity. When a RecBCD com-
plex is engaged in processing duplex DNA and a specific 8-nt
sequence called x is encountered, the 39 to 59 exonuclease
activity of RecBCD is attenuated, but the enzyme retains both
helicase and 59 to 39 exonuclease activity (42). Attenuation of the
39 to 59 activity leads to formation of ssDNA tracts with 39 ends
as the enzyme travels away from x. In an in vitro reaction
containing linear duplex, a homologous supercoiled plasmid,
SSB, RecA, and RecBCD, x stimulates the strand exchange
between the 39 ssDNA end in the linear DNA created by
RecBCD and the supercoiled plasmid (43). In addition to
creating the ssDNA substrate for this ‘‘coupled’’ nuclease–
recombinase reaction, RecBCD promotes assembly of RecA on
the 39 ssDNA molecules it creates (44–48). Thus, E. coli uses two
different mechanisms to build RecA filaments at sites of DNA
damage in wild-type (WT) cells; RecBCD promotes assembly of
RecA at DNA ends, whereas RecFOR controls assembly of
RecA at single-strand gaps. This functional specialization is not
strict however; genetic suppressor studies suggest that RecFOR
can substitute for RecBCD in promoting recombination of DNA
ends (6).
Mediator Proteins in Eukaryotes. Both the S. cerevisiae Rad52 and
heterodimeric Rad55yRad57 have been shown to have mediator
function in vitro (35, 49–52). Both Rad52 and Rad55y57 can
overcome inhibition of Rad51-mediated strand exchange by
RPA. Human Rad52 even stimulates Rad51 reactions indepen-
dent of the effects of RPA (53, 54). Although Rad52 stimulates
assembly of Rad51, other observations indicate that it has
additional activities that can promote recombination. Rad52 has
been shown to promote annealing of complementary ssDNA
(55, 56), an activity that may account for the ability of rad51
mutant strains to carry out limited but significant amounts of
recombination. Rad52 forms heptameric ring structures (56, 57)
that bind selectively to ssDNA ends (58).
The role of RAD55, RAD57, and RAD52 in assembly of Rad51
has been examined in vivo by using cytological techniques (29).
During meiosis in the budding yeast S. cerevisiae, Rad51 foci
appear transiently during normal meiotic recombination, but no
foci are seen in rad55, rad57, or rad52 mutants, suggesting both
Rad52 and Rad55y57 are required for Rad51 assembly in
meiosis.
Recombination proteins also influence the assembly of the
meiosis-specific RecA homologue, Dmc1. In this case, Rad51 is
important for normal assembly of Dmc1 (23, 30). However,
assembly of Dmc1 was found to be independent of Rad52 (23,
59). This result was surprising, because formation of Rad51 foci
depends on Rad52. Our current interpretation of the lack of
dependence of Dmc1 foci on Rad52 is that Rad51’s ability to
promote Dmc1 assembly is independent of its ability to oli-
gomerize into a cytologically detectable structure. Perhaps
Rad55, Rad57, and Rad51 can form a heterotrimer or other
lower-order heterooligomer that serves as a mediator for Dmc1.
A recent study has also shown that another recombination
accessory factor, Tid1 (also known as Rdh54), is required to
coordinate the assembly of Dmc1 foci at sites of Rad51 foci (30).
Tid1 can bind directly to both Rad51 and Dmc1 (24), raising the
possibility that it serves as an intermolecular bridge between
these two proteins during assembly.
In higher eukaryotes, mammalian Rad52 is the only protein
shown by biochemical methods to promote Rad51 assembly (54).
However, cytological studies provide evidence for additional
assembly factors. Xrcc3, an orthologue of yeast Rad57 (60), was
found to be required for assembly of Rad51 foci after DNA
damage in Chinese hamster ovary cells (CHO) (61). Xrcc3 is one
of five paralogues of Rad51 found in mammalian cells (Table 1).
All five Rad51 paralogues were recently shown, by cytological
methods, to be important for Rad51 assembly after x-ray treat-
ment of chicken DT40 cells (82–84). This led Takeda and
colleagues to propose that the five may function together as a
single mediator complex.
In addition to the Rad51 paralogues, the breast cancer sus-
ceptibility genes BRCA1 (85) and BRCA2 (86) have been shown
to be important for formation of Rad51 foci after DNA damage.
The BRCA proteins had been shown previously to associate with
Rad51 (75–81) and to colocalize with damage-induced Rad51
foci (87, 88). These results suggested that the BRCA proteins
might act directly to promote assembly. Analysis of a cell line that
expresses a truncated form of BRCA2 showed failure of both
BRCA2 and Rad51 to localize to the nucleus (89). Thus, it is
possible that BRCA2’s role in assembly is limited to nuclear
transport of Rad51. Biochemical studies are required to deter-
mine which of the many vertebrate proteins required for sub-
nuclear Rad51 assembly in vivo are directly involved.
Beginning with the biochemical studies of Alberts and col-
leagues (62), mediator proteins have been found to interact both
with ssbs and with recombinases (see Table 1). In the T4 system,
as well as in the bacterial and eukaryotic systems, direct inter-
actions have been detected between mediators and ssb andyor
between mediators and recombinase (reviewed in ref. 35). These
interactions have been proposed to remodel ssb–ssDNA com-
plexes forming structures more accessible for recombinase fila-
ment initiation and to recruit recombinase to the sites of
ssDNA–ssb-mediator complexes (35, 39, 49–51, 54, 90, 91). Such
recruitment of recombinase to ssDNA appears to be particularly
important in the case of Rad51, because this protein has no
preference for ssDNA over dsDNA in vitro (4).
The Role of Mediator Proteins in Rad51 Assembly After DNA Damage.
To determine whether proteins known to have in vitro mediator
activity are required for formation of Rad51 foci after mitotic
DNA damage, exponentially growing WT and mutant cells were
g-irradiated in parallel. At various times after irradiation, cells
were spheroplasted, and spread nuclei were prepared. The rad52
and rad55 single mutants used were the same as those used
previously to examine the role of RAD52 and RAD55 in meiosis
(29). An isogenic rad55 rad52 double mutant was also examined.
Because the radiation sensitivity of rad55-null mutants is more
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pronounced at low temperatures, experiments were carried out
at both 20°C and 30°C. The results are shown in Fig. 3. All strains
examined showed significant induction of Rad51 foci after
irradiation. The number of foci continued to increase during the
interval examined (up to 5 h). In striking contrast to the previous
meiotic experiments, radiation-induced mitotic Rad51 foci were
observed in the rad52 and rad55 single mutants. Significant
induction of foci was detected even in the rad52 rad55 double
mutant, indicating formation of foci after radiation of mitotic
cells does not depend strictly on either Rad55 or Rad52.
Although focus induction was observed in rad55 and rad52
mutants, there were significant and reproducible differences in
the rate of focus accumulation in the mutant strains as compared
with WT. At 20°C, the rad55 mutant accumulated foci at a slower
rate than WT; the mutant displayed fewer foci than WT at all
times after induction (P , 0.025). In contrast to rad55, differ-
ences between WT and the rad52 single mutant were not
significant except for the 1-hr sample. The number of foci seen
in the rad52 rad55 double mutant was not significantly less than
that seen in the rad55 single mutant at 2, 3, and 5 h. Thus, RAD55
is required for the normal efficiency of focus induction at 20°C,
whereas RAD52 is largely dispensable. A rad52 rad55 rad57 triple
mutant was also examined and showed the same efficiency of
focus induction as a rad55 rad52 mutant, indicating that RAD57
is not required for the residual Rad51 focus formation detected
in the absence of RAD55 and RAD52 (59).
The rad55 mutant showed a much smaller defect in Rad51
focus induction at 30°C than at 20°C. The rate of focus appear-
ance in the rad55 mutant was about 2.5 greater at 30°C than at
20°C, and this difference was significant (P , 0.005), indicating
that focus formation is cold sensitive in rad55 mutants.
The rad52 single mutant showed a more pronounced lag in
Rad51 focus formation at 30°C than at 20°C; significantly fewer
foci were seen in rad52 than in WT at 1 and 2 h, indicating that
the timing of focus induction is delayed in the mutant. Of
particular importance is the observation that the rad52 rad55
double mutant assembled fewer Rad51 foci than either the rad55
or the rad52 single mutant at 30°C (P , 0.005 for the 2-, 3- and
5-h time points). These results suggest that RAD52 and RAD55
can substitute for one another in promoting focus formation at
30°C. Taken together, the results indicate that RAD52 can
promote nearly normal numbers of Rad51 foci in the absence of
RAD55, at 30°C but not at 20°C. Lovett and Mortimer originally
proposed that ‘‘RAD55 and RAD57 participate in a process for
which a functional substitute exists,’’ and that ‘‘this alternative
process may be naturally temperature-dependent’’ (92). The
results presented here suggest that the naturally temperature-
dependent process is Rad52-promoted assembly of Rad51.
The results raise the question of which of the two mediators,
Rad52 or Rad55y57, acts normally in WT cells to promote
Rad51 assembly. It is possible that Rad55y57 is the predominant
assembly factor at all temperatures, with Rad52 acting only when
Rad55y57 is defective. This seems somewhat unlikely, given that
the rad52 single mutant showed a significant delay in Rad51
assembly at 30°C. A second possibility is that Rad52 promotes
most assembly at 30°C, with Rad55y57 acting in repair only when
cells happen to be in a cool environment and when they enter the
meiotic pathway. Note that rad55 and rad57 are defective in
meiosis even at 30°C, consistent with observed defect in Rad51
focus formation (29, 92). In this context, it is important to point
out that although the rad52 mutant showed little defect in the
efficiency of focus induction at low temperature, it is not possible
to conclude from cytological observations that the structures
observed in this or any other mutant strain are functionally
normal. The biochemical properties of Rad52 suggest one way in
which the Rad51 foci that form in rad52 mutant might be
Table 1. Recombinases and assembly factors
rec ssb Mediator
Mediator interactions*
ssb rec Indirect
T4 UvsX gp32 UvsY (62, 63) (62)
E. coli RecA SSB RecO (39)
RecR RecO (39)
RecF† RecR (64)
RecBCD‡
S. cerevisiae Rad51 RPA Rad52 (65) (66–68)
Rad55 (67, 69)
Rad57 Rad55 (52, 67, 69)
Vertebrates Rad51 RPA Rad52 (70) (71)
[Xrcc2]§ Rad51D (72)
[Xrcc3] (73)
[Rad51B] Rad51C (74)
[Rad51C] (72) Xrcc3 (72)
[Rad51D] Rad51C (72)
[Brca1] (75)¶ Brca2 (76)
[Brca2] (77, 81)
*Evidence for interaction includes biochemical (e.g.; affinity chromatography, immune precipitation, chemical
cross-linking), and two-hybrid data.
†Although RecF has not been found to contribute to mediator activity directly, it can influence assembly of RecA
and associates directly with RecR.
‡RecBCD has been shown to promote assembly of RecA, although the mechanism may not involve displacement
of SSB from ssDNA. Although there is no showing direct evidence for protein–protein interactions, the properties
of certain RecB mutants strongly suggest that it is the subunit of RecBCD most closely involved in RecA assembly.
§The proteins listed in parentheses have not been shown by biochemical experiments to be mediators. However,
these protein are considered to be ‘‘putative mediators’’, based on two properties: they bind directly or indirectly
to recombinase via protein–protein interactions, and they are required for assembly of recombinase at sites of
damage in vivo. (Xrcc3 is a likely orthologue of yeast Rad57, a known mediator protein.) We do not list proteins
that influence recombinase assembly but are likely to act by posttranscriptional modification of recombinase.
¶The interactions detected in this paper could have been direct or indirect protein–protein interactions with
Rad51.
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abnormal. Rad52 binds selectively to DNA ends (58). It is
possible that Rad52 normally directs initiation of Rad51 fila-
ments to DNA ends created by radiation, and that only filaments
that initiate near ends are fully functional in repair. These
considerations could provide an explanation for why the radia-
tion sensitivity of rad52 mutants is greater than that of rad55 and
rad57 mutants even at cold temperature.
Significant numbers of foci were induced by radiation in a
mutant that eliminates all three known mediator proteins,
Rad55, Rad57, and Rad52. There are three hypotheses that can
account for this observation. First, there could be additional
mediator proteins, yet to be identified, that act in the absence of
Rad55y57 and Rad52. Second, aberrant structures, which are
cytologically indistinguishable from repair-associated structures,
may form as a default mechanism when normal assembly is
blocked. Third, a fraction of radiation-induced recombination
events may involve mediator-independent assembly of Rad51
into functional complexes (or such assembly may occur when
mediators are absent). Biochemical and genetic experiments
provide support for this last possibility. Residual Rad51 activity
is detected in the absence of mediators at high ssb concentrations
(22, 49–52), and overexpression of Rad51 can suppress the
phenotypes of mutations that eliminate mediator function (66,
69, 93, 94) (S.L.G., E. Aselson, D. Livingston, and D.K.B.,
unpublished results).
Spontaneous Rad51 Foci. To determine whether Rad51 foci were
present in undamaged yeast cells, aliquots from log phase
cultures were examined without any prior damaging treatment.
Control experiments by using a rad51 null mutant indicated that
the majority of foci detected in the RAD511 strains used in this
experiment did contain Rad51. An average of about 1.2 6 1.7 SD
fociynucleus were observed in untreated WT cells and 3.8 6 4.5
SD fociynucleus in rad52. We interpret these data under the
assumption that the same number of ‘‘Rad51-provoking’’ lesions
occur in WT and rad52. That the number of Rad51 foci is greater
in rad52 than in WT is likely to indicate that the lifespan of the
foci observed is longer in the mutant. Other observations
indicate that disappearance of Rad51 foci is coupled with
completion of recombination (23, 29, 30). Thus, the great
number of foci observed in the mutant could indicate Rad52 is
required either for assembly of functional Rad51 complexes (as
discussed above), or that it is required for recombination at a
postassembly stage. If the Rad51 foci seen in the rad52 mutant
reflect the number of lesions normally repaired by Rad51, yeast
cells suffer an average of at least four such lesions. For related
observations on Rad52 localization, see ref. 95.
Meiotic vs. Mitotic Assembly of Rad51. The role of Rad52 and
Rad55y57 in assembly of Rad51 in mitotic cells after irradiation
differs considerably from their role in meiosis. The two proteins
appear to be able to substitute for each other in promoting the
assembly of Rad51 after irradiation of mitotic cells. Again, this
result is consistent with the biochemical finding that both
Rad55y57 alone and Rad52 alone have mediator function in
purified systems. In contrast to the requirements after mitotic
DNA damage, both Rad55 and Rad52 are required for detect-
able assembly of Rad51 in meiosis. One possibility is that the
enhanced mediator requirement in meiosis results from the fact
that meiotic DSBs form in a highly regulated context. Several
genes are required for the formation of meiotic DSBs (96), and
the continued association of one or more of the corresponding
proteins could create an assembly barrier that only the combined
functions of Rad52 and Rad55y57 can overcome. However, a
preliminary experiment indicated that radiation induction of
Rad51 foci in meiosis depends strongly Rad52. This suggests that
meiotic breaks need not form in the normal context to display
strict mediator requirements (S.G. and D.K.B., unpublished
work). If this result proves to be reproducible, it is likely that
some difference in the expression of a factor controlling Rad51
assembly in meiosis as compared with mitosis is responsible for
the observed difference in mediator requirement.
Do Mediators Promote Rad51 Assembly Before RPA Assembly in
Meiosis? As mentioned previously, Ashley and colleagues found
that Rad51 foci appeared at an earlier stage in meiosis than RPA
foci (33). They proposed that Rad51 assembles in an inactive
form before DSBs occur, and that RPA activates these com-
plexes at the DSB stage. However, recent results indicate that
formation of Rad51 foci depends on DSBs in the mouse (97) as
it does in yeast (29). Thus, in mouse, Rad51 foci are likely to
assemble at the sites of DSBs without prior assembly of visible
quantities of RPA. Determining whether RPA or Rad51 asso-
ciates first in yeast was complicated by the presence of replica-
tion-associated RPA foci at the times when Rad51 foci first
appeared (29). However, we found that the subset of DSB-
dependent RPA foci appeared at the same time as Rad51 foci.
We also found that RPA foci appeared with normal kinetics in
rad51 mutants and in rad55, rad57, and rad52 mutants. These
results, along with biochemical data on Rad52 and Rad55y57
function, prompted us to propose that Rad51 assembles at the
sites of prior RPA assembly during yeast meiosis, as we have
shown here for Rad51 assembly after mitotic DNA damage.
However, the available meiotic data leave open the possibility
that the mediator-promoted Rad51 assembly occurs before RPA
assembly in both yeast and mouse. Furthermore, some of the
Fig. 3. Role of S. cerevisiae mediators in assembly of Rad51 after g-irradia-
tion. Log phase diploid cells were irradiated to a dose of 100 krads and
incubated in rich medium for the times indicated. All strains used were
isogenic derivatives of SK-1. Mutants contain homozygous deletion alleles.
Wilcoxon sum of ranks tests were used to assess the statistical significance of
differences between samples referred to in the text. (A) The left column shows
the distribution of focus counts at 0 and 2 h after irradiation from 20°C
cultures, the right column from 30°C cultures. Focus counts from 50 unselected
nuclei are displayed in ascending order. (B) Average number of foci plotted as
a function of time for each of the strains examined. For detailed methods, see
ref. 59.
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Rad51 foci observed in the radiation experiments described
above did not colocalize with RPA, making it possible that a
subset of damage-induced Rad51 foci might also assemble at
sites not bound by RPA.
A model designed to account for assembly of Rad51 before
RPA during meiotic recombination is shown in Fig. 4. In order
for Rad51 to outcompete RPA for binding sites on ssDNA, the
model proposes that initiation of Rad51 assembly be mechanis-
tically coupled to the nucleolytic processing of DNA ends.
(Under the nuclease-recombinase coupling model, the observa-
tion that RPA foci form in recombinase and mediator mutants
is explained as a default pathway.) Rad52 binds to ssDNA ends
and, with the help of Rad55y57, initiates a Rad51 filament
before nucleolytic activity allows an inhibitory RPA filament to
form. Although this model remains to be tested, coupling of
recombinase assembly to nucleolytic processing of ends has
precedent. As discussed above, RecBCD-dependent stimulation
of RecA assembly at x sites involves coupling of ssDNA forma-
tion and recombinase assembly. In addition, the T4-encoded
nuclease gp46y47 associates strongly with UvsY, the bacterio-
phage T4 mediator, raising the possibility that recombinase
assembly can be coupled to formation of ssDNA tracts in that
system as well (35). This observation could be relevant to
eukaryotes, given that gp46y47 nuclease complex is structurally
related to the yeast Mre11yRad50yXrs2 complex (98), which
controls both formation and nucleolytic processing of meiotic
DSBs (99).
An alternative way to explain assembly of Rad51 before RPA
in meiosis would be an alteration in the binding properties of
RPA andyor Rad51 that enhanced Rad51’s ability to compete
with RPA for binding sites on ssDNA. This possibility seems
unlikely to us, given that the requirement for mediators is stricter
in meiosis than in mitosis. On the other hand, posttranslational
modification of both Rad51 and RPA has been observed (as
discussed further below), and such modifications could influence
the mechanism of assembly during meiosis andyor mitosis.
Other Factors Controlling Rad51 Assembly. Mammalian cells in
growing cultures are heterogeneous with respect to their ability
to form Rad51 foci in response to radiation (27, 28, 61, 100). This
heterogeneity does not appear to be accounted for by a random
distribution of foci among cells; instead, there appear to be two
populations of cells, those that can be induced to form many foci
and those that fail to respond. Studies of steady-state mRNA and
protein levels have shown that expression of the RAD51 gene is
low in serum-starved (G0) cells (101, 102). RAD51 mRNA levels
are reported to be highest at the G1yS boundary and protein
levels highest in G2. However, although the level of transcript
was low in G0 cells, the observed changes in expression during
cell cycle progression were quite modest (less than 3-fold).
Nonetheless, the observation that the steady-state level of Rad51
is not altered by radiation (61), together with the data on cell
cycle control of Rad51 expression, suggested that it is cells in G1
that are incapable of responding to radiation by forming Rad51
foci. To test the idea directly, we fractionated cycling CHO cells
by centrifugal elutriation and tested each fraction’s ability to
form Rad51 foci in response to a dose of x-rays. The results are
shown in Fig. 5. The results clearly show that fractions containing
predominantly G1 cells failed to form foci in response to
Fig. 4. Model for mediator-dependent coupling of ssDNA strand resection
and recombinase assembly at DSBs during meiosis. (A) Strand-specific nuclease
loads at DSB sites. (B) Mediators are loaded on DNA ends before nuclease
proceeds a distance far enough to allow cytologically detectable amounts of
RPA. (C) Rad51 is recruited to ends via mediator interactions, again before
nuclease has proceeded far from the end. (D) Nucleolytic resection of DNA
occurs in concert with elongation of the Rad51 filament. (E) Rad51 carries out
homology search. (F) Strand exchange occurs with RPA loading on the out-
going ssDNA strand.
Fig. 5. Radiation induction of Rad51 foci is cell cycle stage dependent.
Subconfluent CHO cells were fractionated by centrifugal elutriation and
aliquots of fractions assayed for DNA content via conventional methods
(propidium iodide staining) on a Becton Dickinson FACScan. Raw data were
analyzed to determine the percentage of the population in G1, S, and G2 by
using CELLQUEST software (Becton Dickinson). The remaining cells in each
fraction were split into two fractions; one fraction was irradiated to a dose of
0.9 krad (9 Gy) x-rays with a Maxitron generator (General Electric), and the
other served as an unirradiated control. All fractions were incubated in culture
medium for 3 h, after which all fractions were analyzed a second time by FACS
and also by immunostaining for Rad51 foci by using a previously published
method (60). (A) Percentage of cells in G1, S, and G2 as estimated by FACS
analysis of each of seven fractions obtained by elutriation. (B) FACS analysis of
untreated fractions after 3-h incubation. (C) FACS analysis of irradiated frac-
tions after 3-h incubation. (D) Percentage of Rad51-focus positive cells in each
untreated fraction after a 3-h incubation in culture medium. (E) Percentage of
Rad51-focus positive cells in each irradiated fraction after a 3-h incubation in
culture medium.
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radiation, whereas those in S phase responded efficiently. A
single fraction (no. 7) contained predominantly G2 cells and this
fraction showed less focus induction than did the previous
fraction that contained mostly S-phase cells at the time of
radiation treatment. However, this result could be misleading
because the number of cells recovered in fraction no. 7 was quite
low, reducing the reliability of FACS analysis. Furthermore, in
other experiments, G2-enriched fractions showed efficient in-
duction of Rad51 foci (data not shown). In contrast to the
variable result with G2-enriched fractions, we consistently see
failure of G1 cells to induce Rad51 foci and efficient induction
of foci in S-phase cells. Induction of recombinational repair
capability in S phase makes biological sense, in that most of the
spontaneous DNA damage repaired by the recombinational
mechanism occurs as a result of detects in replication (see ref.
103 and references therein).
Although changes in Rad51 expression level alone could
account for the failure of G1 (and possibly G2) cells to form
Rad51 foci in response to radiation, other regulatory processes
may influence this response as well. Several lines of evidence
from mammalian cells and yeast indicate that RPA, Rad51, and
Rad55 are all phosphorylated in response to radiation (104–
108). Phosophorylation of these proteins is mediated by mem-
bers of the ATM family of protein kinases in mammals and yeast.
The activity of these kinases is induced in response to damage.
ATM-dependent phosphorylation of Rad51 is mediated indi-
rectly through ATM-dependent activation of the nonreceptor
tyrosine kinase c-Abl (107, 108). One study found that phos-
phorylation of Rad51 by c-Abl increased Rad51-Rad52 interac-
tion (108), a change that would be expected to enhance assembly
of Rad51 in response to damage. However, another study found
that phosphorylated Rad51 had reduced ability to bind ssDNA
and was inactive in strand exchange reactions (107). Perhaps two
pools of Rad51 are required for an efficient repair after damage,
a phosphorylated pool to promote filament initiation via Rad52
interaction and an unphosphorylated pool critical for filament
elongation and strand exchange. Another possibility is that
phosphorylation of Rad51 contributes to cell-cycle regulation of
Rad51 activity. Further studies are required to determine the
role of posttranslational modification in assembly of recombi-
nation complexes in vivo and in vitro.
Future Directions for the Study of Recombinase Assembly. Substan-
tial progress has been made in the last few years on the
mechanisms that promote assembly of RecA-like recombinases.
Important questions remain to be addressed. What are the
structural intermediates involved in recombinase assembly?
How is mediator activity regulated to ensure that recombinase
assembles only at sites of DNA damage and not on the tracts of
ssDNA that form as normal intermediates in DNA replication?
Does mediator binding at DNA ends play an important part in
recombinase assembly? Are the requirements for assembly at
ends different from the requirements for assembly at daughter
strand gaps? Why are mediator requirements stricter in meiosis
than in mitosis? Does down-regulation of Rad51 protein alone
account for the inability of G1 cells to form Rad51 foci in
response to damage, or are other regulatory mechanisms in
place? What role does damage-dependent phosphorylation play
in recombinase assembly?
Bacteriophages have often provided paradigms of broad rel-
evance to biological systems. This is certainly true in the case of
recombinase assembly where the lessons learned from phage
have guided experiments in bacteria, yeast, and higher eu-
karyotes. On the other hand, demonstration of different medi-
ator requirements in mitosis and meiosis contributes to evidence
indicating that some of the mechanisms regulating assembly of
recombination complexes are unique to eukaryotes.
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